Wordt geladen...
Small Molecule “Silmitasertib” Repurposed as Inhibitor of Transforming Growth Factor Beta 1 for the Development of Therapeutics for Oral Submucous Fibrosis
Oral submucous fibrosis (OSMF) is considered a premalignant condition characterized by aggressive fibrosis of the submucosal tissues of the oral cavity reflecting its malignant transformation potential. Activation of transforming growth factor beta (TGF-β) signaling has been reported to lead increas...
Bewaard in:
| Gepubliceerd in: | Biomed Res Int |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Hindawi
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8035005/ https://ncbi.nlm.nih.gov/pubmed/33869629 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/6631848 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|